Two new proteases in the MHC class I processing pathway

Nature Immunology

Volumn 1, Issue 5, 2000, Pages 413-418

  Stoltze, Lars ^a   Schirle, Markus ^a   Schwarz, Gerold ^a   Schröter, Christian ^a   Thompson, Michael W ^b   Hersh, Louis B ^b   Kalbacher, Hubert ^a   Stevanovic, Stefan ^a   Rammensee, Hans Georg ^a   Schild, Hansjörg ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYL ALANYL PHENYLALANINE CHLOROMETHYL KETONE; ALANYL-ALANYL-PHENYLALANINE CHLOROMETHYL KETONE; AMINOPEPTIDASE; BLEOMYCIN HYDROLASE; CYSTEINE PROTEINASE; ENKEPHALIN DEGRADING ENZYME; EPITOPE; HLA ANTIGEN CLASS 1; LIGAND; MULTIENZYME COMPLEX; NUCLEOCAPSID PROTEIN; PEPTIDE CHLOROMETHYL KETONE; PROTEASOME; PROTEINASE; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN PROCESSING; VESICULAR STOMATITIS VIRUS; VIRUS NUCLEOCAPSID;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID SEQUENCE; AMINOPEPTIDASES; ANIMALS; ANTIGENS, VIRAL; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 5944236047     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/80852     Document Type: Article

References (32)

1. Cerundolo, V. et al. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27, 336-341 (1997).
2. Falk, K., Rotzschke, O. & Rammensee, H. -G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348, 243-251 (1990).
3. Snyder, H. L., Yewdell, J. W. & Bennink, J. R. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180, 2389-2394 (1994).
4. Elliott, T., Willis, A., Cerundolo, V. & Townsend, A. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181, 1481-1491 (1995).
5. Lobigs, M., Chelvanayagam, G. & Mullbacher, A. Proteolytic processing of peptides in the lumen of the endoplasmic reticulum for antigen presentation by major histocompatibility class I. Eur. J. Immunol. 30, 1496-1506 (2000).
6. Beninga, J., Rock, K. L. & Goldberg, A. L. Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273, 18734-18742 (1998).
7. Geier, E. et al. A giant protease with potential to substitute for some functions of the proteasome. Science 283, 978-981 (1999).
8. Stoltze, L. et al. Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur. J. Immunol. 28, 4029-4036 (1993).
9. Paz, P., Brouwenstijn, N., Perry, R. & Shastri, N. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 11, 241-251 (1999).
10. Emmerich, N. P. et al. The human 26S and 20S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate. J. Biol. Chem. (submitted, 2000).
11. Hughes, E. A., Ortmann, B., Surman, M. & Cresswell, P. The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J. Exp. Med. 183, 1569-1573 (1996).
12. Rose, C. et al. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 380, 403-409 (1996).
13. O'Farrell, P.A. et al. Crystal structure of human bleomycin hydrolase, a self-compartmentalizing cysteine protease. Structure Fold. Des. 7, 619-627 (1999).
14. Constam, D. B. et al. Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. J. Biol. Chem. 270, 26931-26939 (1995).
15. Enenkel, C. & Wolf, D. H. BLH1 codes for a yeast thiol aminopeptidase, the equivalent of mammalian bleomycin hydrolase. J. Biol. Chem. 268, 7036-7043 (1993).
16. Craiu, A., Akopian, T., Goldberg, A. & Rock, K. L. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl Acad. Sci. USA 94, 10850-10855 (1997).
17. Hersh, L. B. Solubilization and characterization of two rat brain membrane-bound aminopeptidases active on Met-enkephalin. Biochemistry 20, 2345-2350 (1981).
18. de Souza, A. N., Bruno, J. A. & Carvalho, K. M. An enkephalin degrading aminopeptidase of human brain preserved during the vertebrate phylogeny. Comp. Biochem. Physiol. C 99, 363-367 (1991).
19. McLellan, S., Dyer, S. H., Rodriguez, G. & Hersh, L. B. Studies on the tissue distribution of the puromycin-sensitive enkephalin-degrading aminopeptidases. J. Neurochem. 51, 1552-1559 (1988).
20. Thompson, M. W., Tobler, A., Fontana, A. & Hersh, L. B. Cloning and analysis of the gene for the human puromycin-sensitive aminopeptidase. Biochem. Biophys. Res. Commun. 258, 234-240 (1999).
21. Lopez, D., Gil-Torregrosa, B. C., Bergmann, C. & Del Val, M. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation. J. Immunol. 164, 5070-5077 (2000).
22. Ferrando, A. A. et al. Gene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolase. J. Biol. Chem. 272, 33298-33304 (1997).
23. Bromme, D., Rossi, A. B., Smeekens, S. P., Anderson, D. C. & Payan, D. G. Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. Biochemistry 35, 6706-6714 (1996).
24. Umezawa, H., Hori, S., Sawa, T., Yoshioka, T. & Takeuchi, T. A bleomycin-inactivating enzyme in mouse liver. J. Antibiot. 27, 419-424 (1974).
25. Koldamova, R. P., Lefterov, I. M., Gadjeva, V. G. & Lazo, J. S. Essential binding and functional domains of human bleomycin hydrolase. Biochemistry 37, 2282-2290 (1998).
26. Anton, L. C. et al. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol. 160, 4859-4868 (1998).
27. Luckey, C. J. et al. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161, 112-121 (1998).
28. Lopez, D. & Del Val, M. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. J. Immunol. 159, 5769-5772 (1997).
29. Koldamova, R. P., Lefterov, I. M., DiSabella, M. T. & Lazo, J. S. An evolutionarily conserved cysteine protease, human bleomycin hydrolase, binds to the human homologue of ubiquitin-conjugating enzyme 9. Mol. Pharmacol. 54, 954-961 (1998).
30. Van Kaer, L. et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533-541 (1994).
31. Fehling, H. J. et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237 (1994).
32. Dick, T. P. et al. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86, 253-262 (1996).